1. Clinical value of isoform-specific detection and targeting of AKT1, AKT2 and AKT3 in breast cancer
    Gizeh Pérez-Tenorio et al, 2014, Breast Cancer Management CrossRef
  2. A Network Pharmacology Study on the Molecular Mechanisms of FDY003 for Breast Cancer Treatment
    Ho-Sung Lee et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  3. Starring Role of Biomarkers and Anticancer Agents as a Major Driver in Precision Medicine of Cancer Therapy
    Suman Kumar Ray et al, 2023, Current Molecular Medicine CrossRef
  4. A Network Pharmacology Analysis of the Systems-Perspective Anticancer Mechanisms of the Herbal Drug FDY2004 for Breast Cancer
    Ho-Sung Lee et al, 2021, Natural Product Communications CrossRef
  5. AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins
    Marina Riggio et al, 2017, Scientific Reports CrossRef
  6. Immunohistochemical Analysis of the Activation Status of the Akt/mTOR/pS6 Signaling Pathway in Oral Lichen Planus
    Georgios Prodromidis et al, 2013, International Journal of Dentistry CrossRef
  7. miRNA-542-3p downregulation promotes trastuzumab resistance in breast cancer cells via AKT activation
    TAO MA et al, 2015, Oncology Reports CrossRef
  8. Force Engages Vinculin and Promotes Tumor Progression by Enhancing PI3K Activation of Phosphatidylinositol (3,4,5)-Triphosphate
    Matthew G. Rubashkin et al, 2014, Cancer Research CrossRef
  9. AKT Isoforms as a Target in Cancer and Immunotherapy
    Daniel J. Smit et al, 2022, PI3K and AKT Isoforms in Immunity CrossRef
  10. MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer
    Umadevi Thirumurthi et al, 2014, Science Signaling CrossRef
  11. The Inositol Polyphosphate 5-Phosphatase PIPP Regulates AKT1-Dependent Breast Cancer Growth and Metastasis
    Lisa M. Ooms et al, 2015, Cancer Cell CrossRef
  12. The Importance of RTK Signaling Genes and their Inhibitors in Breast Cancer
    Maryam Rahimi et al, 2022, Journal of Obstetrics, Gynecology and Cancer Research CrossRef
  13. Classifying cancer genome aberrations by their mutually exclusive effects on transcription
    Jonathan B. Dayton et al, 2017, BMC Medical Genomics CrossRef
  14. Distinct functions of AKT isoforms in breast cancer: a comprehensive review
    Nico Hinz et al, 2019, Cell Communication and Signaling CrossRef
  15. Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer
    P Y Yip et al, 2014, Journal of Clinical Pathology CrossRef
  16. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine
    Hala Fawzy Mohamed Kamel et al, 2017, Genomics, Proteomics & Bioinformatics CrossRef